Antibiotic resistance represents a serious threat worldwide. When considering the increasing ability of bacteria to effectively resist antibacterial agents, it is necessary to reduce the consumption of antibiotic substances in animal production in order to preserve their effectiveness in the future. Attention should be paid to the multidrug resistant microorganisms' occurrence, which can be very exhausting for the breeder not only from the economic point of view. Therefore, alternative sources of antibacterials should be considered due to the limited possibilities of using conventional antibiotics in animal breeding, e.g. application of various substances including organic acids, clay minerals, etc. Nowadays, the research in this field also focuses on the combinatory effect of such compounds, which can also find the perspective for use in animal breeding. This article provides an overview of problems connected with the resistance of diverse bacteria to antibiotic treatment in livestock breeding. It emphasises the need for alternate resources usage with the aim to lower the environmental burden caused by overuse of antimicrobials used in subclinical doses in the past and with the expanding bacterial resistance.
a n i m a l S c i e n c e S
INTRODUCTION
The occurrence of alimentary diseases is a serious threat for inhabitants of both developed (H a v e l a a r et al., 2010) and developing (B y a r u g a b a , 2004) countries connected primarily to inappropriate dealing with products of animal origin, their further modifications, and consumption. Since the undesirable bacterial contamination is one of the agents causing food-borne diseases (L e v i n , A n t i a , 2001), its eradication is sought already at the beginning of food-production process: in animal breeding. This can be achieved by using various antimicrobials, such as antibiotics. These are anti-effective drugs discovered from natural and chemical products and derived semi-synthetically with phenotypic methods during the second half of the 20 th century (P o w e r , 2006). Generally, three periods of bacterial diseases' therapy are distinguished: pre-antibiotic, antibiotic, and period of antibiotic resistance's development that is happening right now (with possible transition back to the principles of preantibiotic period in certain countries). Antibiotics have been used to decrease the infectious pressure causing difficulties in animal husbandry and across human population since their discovery (A m i n o v , 2010). Antibiotics for treating diseases, and in prevention as prophylactic agents against bacterial infections and as antibiotic growth promoters (AGPs) have been used in animal production (Table 1) since the very beginnings of antibiotic therapy with the aim to maximise production and to get the highest possible profit (M o o r e et al., 1946; J u k e s et al., 1950) . Using AGPs for longer term may lead to the natural selection of surviving resistant bacteria and strains able to transport such an ability to other bacterium and make them resistant (A a r e s t r u p , 1999). The ability of microorganisms to conquer antibiotic treatment by different mechanisms is called antibiotic resistance (R o n q u i l l o , H e r n a n d e z , 2017). This property is not a novel phenomenon -contrariwise is true: healthcare systems worldwide are facing this situation both in human and veterinary medicine since the very beginnings of antibiotic's treatment applications (B a r b o s a , L e v y , 2000). For example, just two years after penicillin has been introduced in 1941 as an anti-staphylococcal treatment, the resistance level increased to 6% and after a decade even to 50% in hospital-acquired infections (B a r b e r , R o z w a d o w s k a -D o w z e n k o , 1948). This makes antibiotic resistance an issue targeting not only medicine, but different fields -politics, economics, biology, sociology and ecology -with unknown result and solution (B a l s a l o b r e et al., 2014).
Increasing number of inhabitants and economic prosperity is globally connected with rising demand for proteins of animal origins resulting in the estimated increase of animal production by 70% to feed the population of 9.6 billion of people living on the Earth by 2050 (G e r b e r et al., 2013). The rise of animal production is logically connected (especially in developing countries) with higher production and usage of antimicrobials in food-producing species according to its above mentioned (sub)therapeutical and growth-promotory activity. This occurrence is supposed to lead to the estimated growth of antibiotic production by 67%, meaning 105.596 (± 3.605) t by 2030. Approximately 2/3 of increase is expected to be due to higher numbers of reared animals, and 1/3 because of the shift towards intensified animal breeding (V a n B o e c k e l et al., 2015). Nowadays, approximately 60% of nation's annual consumption of medically important antimicrobials in the USA are used for disease prevention and growth promotion in food-producing animals (F D A , 2017). According to previously stated data of production and consumption of antibacterial compounds (more than 1 t per day in various European countries), it is rational to mention that the progression of bacterial resistance against antibiotics is going to evolve further, and is one of the best documented cases of biological evolution in progress even nowadays (B a q u e r o , B l a z q u e z , 1997).
To understand the resistance of bacteria against antimicrobials, it is necessary to know the bacterial mechanisms of resistance and to clarify the impact of resistant bacteria on humans. This is going to be described further in next paragraphs altogether with the summary of possible precautions that can be made in order to preserve the ability of antibiotics to effectively act against bacteria in the future.
Mechanisms of resistance
Both mutation and selection for the growth when higher concentrations of antibiotics are used, contribute to the increase in profound ability of microorganisms to resist the antimicrobial effect of various compounds, as well as acquiring other factors of resistance (B e r g e r -B a c h i , 2005). Rich variability of mechanisms that cause resistance gains an ability to defeat antibiotics in microorganisms, increases their chance to survive in environment containing antibiotics, and allows researchers even to predict a probability of resistance's origins itself. The resistance is believed to be originating out of so-called 'pre-resistant molecules' that arose during different evolutionary processes -e.g. appearance of thirty genes able to modify aminoglycosides (P a y i e et al., 1995), or seventeen genes for resistance against ) antibiotic destruction -e.g. beta-lactamases influence on beta-lactam antibiotics (S a n d a n a y a k a , P r a s h a d , 2002), and (c) elimination of antibiotic out of the cell -e.g. elimination by efflux pump (S o t o , 2013). Generally, this categorisation is artificial, and not every mechanism is possible to sort into mentioned groups. As an example, so-called 'kin selection' can be used. This mechanism of resistance roots in an ability of drug resistant mutants of bacteria to shield the less resistant isolates by production of certain metabolite under antibiotic stress (L e e et al., 2010). Therefore, kin selection can cause difficulties when trying to eradicate populations of diverse bacterial strains or species as in biofilms.
Health-threatening bacteria
Nowadays, there are no commercially available antibiotics at disposal that do not exhibit any bacterial resistance pattern against at least a single microorganism ( B r a c h m a n , A b r u t y n , 2009; C u s h n i e , L a m b , 2011). The European Centre for Disease Control and Prevention (ECDC) oversees resistant microorganisms within the EARS-Net Surveillance Network on Antibiotic Resistance (EARS-Net) in the European Union. ECDC sets sensitivity/resistance criteria of microorganisms to antibiotics and settles rules for detection methods of resistance for these microorganisms: Acinetobacter spp., (Fig. 1) . In the case of Clostridium perfringens, the world's most widespread pathogen, which produces many endotoxins and exotoxins, the acquisition of resistance properties is gradually being started, and this problem needs to be taken into consideration in a timely manner (R a i n e y et al., 2009). Another important factor contributing to the increase of bacterial resistance to antibiotics is the ability of some of the above-mentioned to form a biofilm (P a r s e k , S i n g h , 2003; K o n g et al., 
Monitoring of resistance
Globally used antimicrobial agents include 27 antibacterial classes, 9 of which are used exclusively in animals (P a g e l , G a u t i e r , 2012). Highest consumption of antibiotics can be observed in poultry and pig farms, but the increasing trend in aquaculture consumption cannot be overlooked. The consumption of antibiotics as growth promoters in the United States, Brazil and Argentina is also not negligible (G e l b a n d et al., 2015). Macrolides, penicillins and tetracyclines, which are the world's best-selling antibiotic groups, are classified as critical in human medicine (W H O , 2011) . The highest resistance is described in poultry among the European Union -from 0.9% in the case of aminoglycosides, 6% in macrolides, and up to 59.6% in tetracyclines. The most significant is the resistance of salmonellas and campylobacters to tetracyclines (5.6-82.4% and 1-87.5%, respectively) and quinolones (3.6-94.1% and 3.96-96.3%, respectively) in broiler breeds (E F S A , 2016). In the United States, 22% resistance to fluoroquinolones and 95.4% to gentamycin is reported in poultry with the highest numbers in salmonella strains resistant to tetracyclines (41-46%) being consistent with the EU, the decreasing trend of resistance is then reported in salmonellas with relation to cephalosporins (decrease from 38 to 18%) within chickens in the retail network (C D C , 2014) . 
Antimicrobial resistance precautions
It is well known that antibiotic pressure will boost the resistance because of the selection allowing only the fittest bacteria to survive even more in the future (M a r t i n e z et al., 2007). Such a circumstance may have a negative impact on profound resistance in multi-drug resistant microorganisms. According to the above-mentioned danger of overuse of antibiotics, there is a need to act -one of the attempts to reduce their overuse has become the awareness of the use of antibiotics in human medicine, and in agriculture the ban on antibiotic growth stimulators (E U , 2003) ( Table 2 ). Options to reduce the consumption of classical antibiotics and prevent the associated development of resistance include alternative sources of substances with antibiotic effects, e. g. prebiotics ( , 2002) . In relation with the previous list of non-antibiotic growth promoters, it is necessary to mention, that also in this group of antimicrobials, restrictions of usage will apply in the future. As an example, the zinc oxide can be used: it has recently been stated that overall benefit-risk balance for veterinary medicinal products containing zinc oxide to be administered orally to food-producing species is negative. This is due to the fact, that the zinc's antidiarrhoeal effect value is not exceeding the value of its accumulation rate in the environment and its potential contribution in increase of the bacterial resistance. According to these findings, no more new marketing authorisations will be issued and the withdrawals of the existing marketing authorisations for veterinary medicinal products containing zinc oxide will be implemented in the European Union (E M E A , 2017). Therefore, another possibility to reduce bacterial antibiotic resistance due to reduced dosage of antibiotics is the use of the combinatory effect of various plants (G a r v e y et al., 2011; P e r v a i z et al., 2016), or synthetic substances (L e f e b v r e et al., 2016) both with each other and in combination with antibiotics. Synergistic reactions of two compounds are clearly beneficial for combating bacterial infections, bringing into treatment a perspective of not only reduction of antibacterial resistance, but also a potential in reduced dosage of individual substances used in the combination; extension of antimicrobial treatment; reduced side effects of individual substances; and lowered environmental burden (A k t a s , D e r b e n t l i , 2016). On the other hand, antagonistic interaction between two solely active agents is able to bring undesirable circumstances into treatment that can be even lifethreatening (C a s c o r b i , 2012). Nevertheless, by theoretical models, antagonism could be useful in reducing the potential for evolving resistance more than synergism that is enhancing it by the selection pressure allowing very strongly resistant bacteria to outlast (M i c h e l et al., 2008).
CONCLUsION
Given the general concerns about the progress of antimicrobial resistance in microorganisms to an extent that is not compatible with available drugs, it is highly desirable to limit the consumption of these pharmaceuticals especially in food-producing animals such as poultry and pigs to the lowest acceptable level. Such a minimisation can be achieved not only through legislative interventions, but also by the prevention of disease or using alternative sources of antibacterial agents and also by the combinatory effect of various compounds. 
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